Iman Barilero

Iman Barilero (El Abed), PharmD, PhD, currently serves as Chief Development Officer at Cytovation ASA, where responsibilities include leading R&D strategies and global regulatory efforts. A member of the teaching faculty at Tufts University School of Medicine, Iman delivers lectures on regulatory science and drug development. Previous roles encompass Chief Regulatory Science Officer at Solid Biosciences, Senior Advisor at Innouvo, and Senior Vice President at multiple organizations, including Axcella Health and POXEL, focusing on regulatory leadership and strategic guidance in drug development. Iman's extensive career features significant contributions to regulatory strategies and product approvals for CNS disorders, oncology, and other therapeutic areas while holding senior leadership positions at Lundbeck, Johnson & Johnson, and Agenus. Educational qualifications include a PhD in Molecular & Cellular Pharmacology from the University of Paris VI, among other certifications and degrees in leadership and international business communications.